These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1508 related articles for article (PubMed ID: 28886622)

  • 1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN; ; ;
    Eur Heart J; 2018 Jan; 39(3):213-260. PubMed ID: 28886622
    [No Abstract]   [Full Text] [Related]  

  • 2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN;
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):34-78. PubMed ID: 29045581
    [No Abstract]   [Full Text] [Related]  

  • 3. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Kolh P; Windecker S; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; ; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol Ç; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; ; Sousa Uva M; Achenbach S; Pepper J; Anyanwu A; Badimon L; Bauersachs J; Baumbach A; Beygui F; Bonaros N; De Carlo M; Deaton C; Dobrev D; Dunning J; Eeckhout E; Gielen S; Hasdai D; Kirchhof P; Luckraz H; Mahrholdt H; Montalescot G; Paparella D; Rastan AJ; Sanmartin M; Sergeant P; Silber S; Tamargo J; ten Berg J; Thiele H; van Geuns RJ; Wagner HO; Wassmann S; Wendler O; Zamorano JL; ;
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):517-92. PubMed ID: 25173601
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    ; Windecker S; Kolh P; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A
    Eur Heart J; 2014 Oct; 35(37):2541-619. PubMed ID: 25173339
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Peticevic M; Roffi M; Steg PG; Windecker S; Zamorano JL
    Kardiol Pol; 2017; 75(12):1217-1299. PubMed ID: 29251754
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
    Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
    BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
    Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
    Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
    Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Focused update on dual antiplatelet treatment : ESC guidelines 2017].
    Schäfer A; Bauersachs J
    Herz; 2017 Dec; 42(8):739-745. PubMed ID: 29043405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2017 European Society of Cardiology (ESC) focused update on dual antiplatelet therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
    Jeppsson A; Petricevic M; Kolh P; Valgimigli M
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):3-4. PubMed ID: 29028979
    [No Abstract]   [Full Text] [Related]  

  • 15. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update ESC-Guideline 2017: Dual Antiplatelet Therapy].
    Massberg S; Polzin A
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1090-1093. PubMed ID: 30060279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions.
    Hudzik B; Błachut A; Lesiak M; Kubica J; Wojakowski W; Gąsior M
    Kardiol Pol; 2022; 80(10):974-989. PubMed ID: 36036339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.